Skip to main content
Erschienen in: Inflammation Research 3/2018

11.11.2017 | Letter to the Editor

Altered mTORC1 signalling may contribute to macrophage dysregulation in hidradenitis suppurativa

verfasst von: Valerio De Vita

Erschienen in: Inflammation Research | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

I have read with interest the paper by Shah and colleagues [1]. The authors have underlined that macrophages play a critical role in the pathogenesis of hidradenitis suppurativa (HS). Dysregulation of macrophage activity is a big culprit in causing chronic tissue inflammation and damage. More specifically, dysregulated activation and proliferation of macrophages contribute to elevated macrophage secretion of pro-inflammatory cytokines and matrix metalloproteases (MMPs), which activate other inflammatory effectors and directly lead to tissue injury. In particular, macrophages are the most numerous inflammatory cells found in HS infiltrate and release numerous pro-inflammatory cytokines such as interleukin (IL)-23 [2], IL-1b [3] and tumour necrosis factor (TNF)-alpha [3, 4], which work to further enhance the inflammation. As a result, macrophages may modify the pericellular environment by influencing other inflammatory cells and may act as key players in the pathogenesis of the disease. This evidence helps to understand why HS patients often have concurrent inflammatory conditions which are also characterized by macrophage dysfunction such as Crohn’s disease and spondyloarthropathy. …
Literatur
1.
Zurück zum Zitat Shah A, Alhusayen R, Amini-Nik S. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa. Inflamm Res. 2017;66:931–945CrossRefPubMed Shah A, Alhusayen R, Amini-Nik S. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa. Inflamm Res. 2017;66:931–945CrossRefPubMed
2.
Zurück zum Zitat Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev. 2004;202:96–105.CrossRefPubMed Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev. 2004;202:96–105.CrossRefPubMed
3.
Zurück zum Zitat Sweeney CM, Tobin AM, Kirby B. Innate immunity in the pathogenesis of psoriasis. Arch Dermatol Res. 2011;303:691–705.CrossRefPubMed Sweeney CM, Tobin AM, Kirby B. Innate immunity in the pathogenesis of psoriasis. Arch Dermatol Res. 2011;303:691–705.CrossRefPubMed
5.
Zurück zum Zitat Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012;441:1–21.CrossRefPubMed Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012;441:1–21.CrossRefPubMed
6.
Zurück zum Zitat Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471–84.CrossRefPubMed Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471–84.CrossRefPubMed
7.
8.
Zurück zum Zitat Balato A, Di Caprio R, Lembo S, Mattii M, Megna M, Schiattarella G, et al. Mammalian target of rapamycin in inflammatory skin conditions. Eur J Inflamm. 2014;12:341–50.CrossRef Balato A, Di Caprio R, Lembo S, Mattii M, Megna M, Schiattarella G, et al. Mammalian target of rapamycin in inflammatory skin conditions. Eur J Inflamm. 2014;12:341–50.CrossRef
9.
Zurück zum Zitat Monfrecola G, Lembo S, Caiazzo G, De Vita V, Di Caprio R, Balato A, Fabbrocini G. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients’ skin. Exp Dermatol. 2016;25:153–125.CrossRefPubMed Monfrecola G, Lembo S, Caiazzo G, De Vita V, Di Caprio R, Balato A, Fabbrocini G. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients’ skin. Exp Dermatol. 2016;25:153–125.CrossRefPubMed
10.
Zurück zum Zitat Monfrecola G, Balato A, Caiazzo G, De Vita V, Di Caprio R, Donnarumma M, et al. Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop. J Eur Acad Dermatol Venereol. 2016;30:1631–3.CrossRefPubMed Monfrecola G, Balato A, Caiazzo G, De Vita V, Di Caprio R, Donnarumma M, et al. Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop. J Eur Acad Dermatol Venereol. 2016;30:1631–3.CrossRefPubMed
11.
Zurück zum Zitat Linke M, Fritsch SD, Sukhbaatar N, Hengstschläger M, Weichhart T. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett. 2017;591:3089–103.CrossRefPubMed Linke M, Fritsch SD, Sukhbaatar N, Hengstschläger M, Weichhart T. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett. 2017;591:3089–103.CrossRefPubMed
12.
Zurück zum Zitat Jones RG, Pearce EJ. MenTORing immunity: mTOR signaling in the development and function of tissue-residentimmune cells. Immunity. 2017;46:730–42.CrossRefPubMedPubMedCentral Jones RG, Pearce EJ. MenTORing immunity: mTOR signaling in the development and function of tissue-residentimmune cells. Immunity. 2017;46:730–42.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun. 2013;4:2834.CrossRefPubMedPubMedCentral Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun. 2013;4:2834.CrossRefPubMedPubMedCentral
14.
15.
Zurück zum Zitat Geeraerts X, Bolli E, Fendt SM, Van Ginderachter JA. Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity. Front Immunol. 2017;8:289.CrossRefPubMedPubMedCentral Geeraerts X, Bolli E, Fendt SM, Van Ginderachter JA. Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity. Front Immunol. 2017;8:289.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345:1250684.CrossRefPubMedPubMedCentral Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345:1250684.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Covarrubias AJ, Aksoylar HI, Horng T. Control of macrophage metabolism and activation by mTOR and Akt signaling. Semin Immunol. 2015;27:286–96.CrossRefPubMedPubMedCentral Covarrubias AJ, Aksoylar HI, Horng T. Control of macrophage metabolism and activation by mTOR and Akt signaling. Semin Immunol. 2015;27:286–96.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Covarrubias AJ, Aksoylar HI, Yu J, Snyder NW, Worth AJ, Iyer SS, et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife. 2016;5:e11612.CrossRefPubMedPubMedCentral Covarrubias AJ, Aksoylar HI, Yu J, Snyder NW, Worth AJ, Iyer SS, et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife. 2016;5:e11612.CrossRefPubMedPubMedCentral
Metadaten
Titel
Altered mTORC1 signalling may contribute to macrophage dysregulation in hidradenitis suppurativa
verfasst von
Valerio De Vita
Publikationsdatum
11.11.2017
Verlag
Springer International Publishing
Erschienen in
Inflammation Research / Ausgabe 3/2018
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-017-1115-6

Weitere Artikel der Ausgabe 3/2018

Inflammation Research 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.